Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'α,10α)-, methanesulfonate (1:1)
Title | Journal |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. | Bioorganic & medicinal chemistry 20121115 |
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
Roles of adenosine and serotonin receptors on the antinociception of sildenafil in the spinal cord of rats. | Yonsei medical journal 20101101 |
High-performance liquid chromatographic determination of dihydroergocristine in a pharmaceutical formulation with fluorescence detection. | Journal of AOAC International 20100101 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary results. | Biopharmaceutics & drug disposition 20080101 |
Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasma. | Current drug metabolism 20051201 |
Spinal gabapentin and antinociception: mechanisms of action. | Journal of Korean medical science 20030401 |